ADNT
Adient plc
ADNT has a slight edge over BABA overall, supported by stronger fundamentals.
BABA
Alibaba Group Holding Limited
BABA has slightly lower modeled downside risk, despite its lower overall score.
ADNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Stable |
ADNT's revenue, profitability, cash flow and balance sheet are all currently stable.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
ADNT PE Valuation
ADNT has no meaningful PE right now: it lost money over the past year.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
ADNT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect ADNT's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over ADNT on the outlook, with more favorable revenue and profitability expectations.
ADNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.69 | — |
| Q3 2026 | -$0.24 | +$3.15 |
ADNT lost $0.24 per share over the past year, a smaller loss than the year before.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over ADNT in the latest year-over-year earnings comparison.
ADNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +1.1% |
| Q2 2026 | $3.9B | +5% |
| Q1 2026 | $3.9B | +7% |
| Q4 2025 | $3.6B | +4.3% |
ADNT has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 1.6% | -0.1 points |
| Q1 2026 | 2% | +9.3 points |
| Q4 2025 | 1.1% | -0.2 points |
| Q3 2025 | 1.7% | N/A |
| Q2 2025 | 1.8% | N/A |
| Q1 2025 | -7.3% | N/A |
| Q4 2024 | 1.3% | N/A |
ADNT's operating margin was 1.6% last quarter, about level with the same quarter a year ago.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over ADNT on profitability, with a higher operating margin.
ADNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $138M | +20% |
| Q1 2026 | $8M | +$98M |
| Q4 2025 | $15M | -67% |
ADNT and BABA do not have enough comparable growth data to identify a winner.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
ADNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -100K shares |
| 1 year | -5.4% | -4.5M shares |
ADNT has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $30M |
| Q1 2026 | — |
| Q4 2025 | $25M |
| Q3 2025 | $50M |
| Q2 2025 | $50M |
| Q1 2025 | — |
| Q4 2024 | $25M |
ADNT spent $105M buying back its own shares over the past year.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
ADNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 6.7x | High |
| Q3 2025 | 6.1x | High |
| Q2 2025 | 6.5x | High |
| Q1 2025 | 7.6x | High |
| Q4 2024 | 3.5x | Elevated |
ADNT's net debt is about 2.5 years of its operating earnings (EBITDA), down from 6.5 years a year ago.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over ADNT on leverage, with a lower net debt burden relative to earnings.
ADNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 8.3 | Oversold |
ADNT's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
ADNT PE vs Consumer Cyclical Sector
| Metric | ADNT | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 18x | 68% above |
| PE % | 59 | 47 | 12 pts above |
ADNT has no meaningful PE right now: it lost money over the past year.
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over ADNT on valuation relative to its sector.
ADNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.0 | 6.8% below |
| 20 week MA | $18.6 | 15% below |
| 50 week MA | $20.3 | 22% below |
| 100 week MA | $19.5 | 19% below |
| 200 week MA | $25.9 | 39% below |
ADNT is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
ADNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.3 | $34.6 | +63% |
| 2021 | $34.6 | $46.9 | +36% |
| 2022 | $46.9 | $34.1 | -27% |
| 2023 | $34.1 | $36.4 | +6.8% |
| 2024 | $36.4 | $17.4 | -52% |
| 2025 | $17.4 | $19.5 | +12% |
| 2026 YTD | $19.5 | $15.8 | -19% |
ADNT has the edge over BABA on returns for 2026, with the stronger performance.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.